Trial · NCT00330876

Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

NCT00330876, Phase 3, Completed, Kowa Research Europe; results first posted 2010-01-18

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia. Trials, record NCT00330876. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00330876

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
NCT number: NCT00330876
Status: Completed
Phases: Phase 3
Enrollment: 545 participants, actual
Lead sponsor: Kowa Research Europe
Conditions: Hypercholesterolemia, Dyslipidemias
Interventions: Pitavastatin
First posted: 2006-05-29
Last updated: 2010-03-16
Results first posted: 2010-01-18

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Change From Baseline in LDL-C	Baseline to 60 weeks	percent change from baseline in low density lipoprotein-cholesterol (LDL-C)
Secondary	Change From Baseline in Total Cholesterol	Baseline to 60 weeks	Percent change from baseline in total cholesterol (TC)

Source ClinicalTrials.gov

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Change From Baseline in LDL-C	Baseline to 60 weeks	Subjects with measurement at Week 60	percent change	MEAN
SECONDARY	Change From Baseline in Total Cholesterol	Baseline to 60 weeks	Subjects with a measurement at Week 60	percent change	MEAN

Source ClinicalTrials.gov

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Value	Spread	Units
Change From Baseline in LDL-C	Pitavastatin 2 mg QD	-43.18	Standard Deviation 10.065	percent change
Change From Baseline in LDL-C	Pitavastatin 4 mg QD	-44.26	Standard Deviation 10.764	percent change
Change From Baseline in Total Cholesterol	Pitavastatin 2 mg QD	-28.27	Standard Deviation 8.214	percent change
Change From Baseline in Total Cholesterol	Pitavastatin 4 mg QD	-30.54	Standard Deviation 8.226	percent change

Source ClinicalTrials.gov

Participant flow6

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	Pitavastatin 2 mg QD	449
Overall Study	STARTED	Pitavastatin 4 mg QD	90
Overall Study	COMPLETED	Pitavastatin 2 mg QD	378
Overall Study	COMPLETED	Pitavastatin 4 mg QD	77
Overall Study	NOT COMPLETED	Pitavastatin 2 mg QD	71
Overall Study	NOT COMPLETED	Pitavastatin 4 mg QD	13

Source ClinicalTrials.gov

Adverse events132

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk
other	Nasopharyngitis	Infections and infestations	Pitavastatin 2 mg QD	71	539
other	Nasopharyngitis	Infections and infestations	Pitavastatin 4 mg QD	2	95
other	Urinary tract infection	Infections and infestations	Pitavastatin 2 mg QD	26	539
other	Urinary tract infection	Infections and infestations	Pitavastatin 4 mg QD	4	95
other	Cystitis	Infections and infestations	Pitavastatin 2 mg QD	26	539
other	Cystitis	Infections and infestations	Pitavastatin 4 mg QD	1	95
other	Myalgia	Musculoskeletal and connective tissue disorders	Pitavastatin 2 mg QD	44	539
other	Myalgia	Musculoskeletal and connective tissue disorders	Pitavastatin 4 mg QD	4	95
other	Arthralgia	Musculoskeletal and connective tissue disorders	Pitavastatin 2 mg QD	34	539
other	Arthralgia	Musculoskeletal and connective tissue disorders	Pitavastatin 4 mg QD	3	95

1 to 10 of 132Source ClinicalTrials.gov

See all 132 adverse events

Adverse event totals6

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Pitavastatin 2 mg QD
Total, all-cause mortality	Pitavastatin 4 mg QD
Total, other adverse events	Pitavastatin 2 mg QD	286
Total, other adverse events	Pitavastatin 4 mg QD	24
Total, serious adverse events	Pitavastatin 2 mg QD	51	449
Total, serious adverse events	Pitavastatin 4 mg QD	7	90

Source ClinicalTrials.gov

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Pitavastatin 2 mg QD vs Pitavastatin 4 mg QD: serious adverse events

Source Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00330876

GET https://conductscience.org/api/trials/v1/NCT00330876/events?page=2

API reference For AI assistants